SCHEMBL469037

SCHEMBL469037

O=S(=O)(Cl)c1ccc(C2CCCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.56
HTT P42858 4/20 0.56
SMN1; SMN2 Q16637 6/20 0.50
KDM4E B2RXH2 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MAPK1 P28482 1/20 0.49
ALDH1A1 P00352 5/20 0.49
MAPT P10636 3/20 0.49
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
TP53 P04637 1/20 0.49
ATM Q13315 1/20 0.49
TSHR P16473 2/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
HPGD P15428 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
XBP1 P17861 1/20 0.44
CHRNA7 P36544 1/20 0.44
PTGES2 Q9H7Z7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931626 0.98 LMNA (0.59) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL23686014 0.98 LMNA (0.59) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL11677845 0.98 LMNA (0.59) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL3590458 0.91 ALDH1A1 (0.46) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL10180298 0.83 LMNA (0.65) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL19127214 0.82 SMN1; SMN2 (0.50) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL30772120 0.82 LMNA (0.40) LMNAHTTSMN1; SMN2KDM4EHSD17B10
Acetic Acid SCHEMBL28760535 0.81 ALDH1A1 (0.42) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL10182181 0.81 LMNA (0.68) LMNAHTTSMN1; SMN2KDM4EHSD17B10
SCHEMBL469038 0.79 LMNA (0.56) LMNAHTTSMN1; SMN2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139456-B2 Chelating compounds and immobilized tethered chelators THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) 2015-09-22 US disclosed
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS THE CURATORS OF THE UNIVERSITY OF MISSOURI 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061325-A1 CHELATING COMPOUNDS AND IMMOBILIZED TETHERED CHELATORS BTD, TTPA, SLC39A7 LMNA 3554/4885HTT 1987/4885SMN1; SMN2 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.